These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24994556)

  • 1. Brain circuit dysfunction in a distinct subset of chronic psychotic patients.
    Goldman MB
    Schizophr Res; 2014 Aug; 157(1-3):204-13. PubMed ID: 24994556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural pathology underlying neuroendocrine dysfunction in schizophrenia.
    Goldman MB; Wang L; Wachi C; Daudi S; Csernansky J; Marlow-O'Connor M; Keedy S; Torres I
    Behav Brain Res; 2011 Mar; 218(1):106-13. PubMed ID: 21093493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.
    Goldman MB; Gomes AM; Carter CS; Lee R
    Psychopharmacology (Berl); 2011 Jul; 216(1):101-10. PubMed ID: 21301811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients.
    Goldman MB; Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Pilla R
    Hippocampus; 2007; 17(7):554-62. PubMed ID: 17427242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.
    Goldman M; Marlow-O'Connor M; Torres I; Carter CS
    Schizophr Res; 2008 Jan; 98(1-3):247-55. PubMed ID: 17961988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients.
    Goldman MB; Robertson GL; Luchins DJ; Hedeker D
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1465-70. PubMed ID: 8636352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain structural changes and neuropsychological impairments in male polydipsic schizophrenia.
    Nagashima T; Inoue M; Kitamura S; Kiuchi K; Kosaka J; Okada K; Kishimoto N; Taoka T; Kichikawa K; Kishimoto T
    BMC Psychiatry; 2012 Nov; 12():210. PubMed ID: 23181904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients.
    Goldman MB; Gnerlich J; Hussain N
    Neuropsychopharmacology; 2007 Jul; 32(7):1611-21. PubMed ID: 17164813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia.
    Goldman MB; Robertson GL; Luchins DJ; Hedeker D; Pandey GN
    Arch Gen Psychiatry; 1997 May; 54(5):443-9. PubMed ID: 9152098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydipsia and hyponatremia in psychiatric patients.
    Illowsky BP; Kirch DG
    Am J Psychiatry; 1988 Jun; 145(6):675-83. PubMed ID: 3285701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary polydipsia: Update.
    Ahmadi L; Goldman MB
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101469. PubMed ID: 33222764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia.
    Shinkai T; De Luca V; Utsunomiya K; Sakata S; Inoue Y; Fukunaka Y; Hwang R; Ohmori O; Kennedy JL; Nakamura J
    Neuromolecular Med; 2008; 10(4):362-7. PubMed ID: 18543120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study.
    Hawken ER; Crookall JM; Reddick D; Millson RC; Milev R; Delva N
    Schizophr Res; 2009 Feb; 107(2-3):128-33. PubMed ID: 18984069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypouricemia in chronic schizophrenic patients with polydipsia and hyponatremia.
    Hanihara T; Amagai I; Hagimoto H; Makimoto Y
    J Clin Psychiatry; 1997 Jun; 58(6):256-60. PubMed ID: 9228891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
    Goldman MB; Wood G; Goldman MB; Gavin M; Paul S; Zaheer S; Fayyaz G; Pilla RS
    J Clin Endocrinol Metab; 2007 Feb; 92(2):698-704. PubMed ID: 17118992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness.
    Goldman MB
    Brain Res Rev; 2009 Oct; 61(2):210-20. PubMed ID: 19595703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia.
    Goldman MB; Luchins DJ; Robertson GL
    N Engl J Med; 1988 Feb; 318(7):397-403. PubMed ID: 3340117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychogenic Polydipsia in a Patient With a Clinical Triad.
    Dodge JT; Kidron A; Cooper BW; Shepard A
    Cureus; 2022 Jul; 14(7):e26651. PubMed ID: 35949782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A different hypothesis on hyponatremia in psychiatric patients: treatment implications and experiences.
    Margetić B; Aukst-Margetić B
    World J Biol Psychiatry; 2009; 10(4 Pt 2):677-81. PubMed ID: 18942040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.